These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9131231)

  • 1. Exposure limits for unconventional shifts: toxicokinetic and toxicodynamic considerations.
    Fiserova-Bergerova V; Vlach J
    Am J Ind Med; 1997 Jun; 31(6):744-55. PubMed ID: 9131231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occupational exposure limits: an approach and calculation aid for extended work schedule adjustments.
    Armstrong TW; Caldwell DJ; Verma DK
    J Occup Environ Hyg; 2005 Nov; 2(11):600-7. PubMed ID: 16234220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of toxicokinetic modeling to the adjustment of exposure limits to unusual work schedules.
    Laparé S; Brodeur J; Tardif R
    AIHA J (Fairfax, Va); 2003; 64(1):17-23. PubMed ID: 12570391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of occupational exposure limits to unusual work schedules.
    Hickey JL; Reist PC
    Am Ind Hyg Assoc J; 1977 Nov; 38(11):613-21. PubMed ID: 930810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear pharmacokinetic models for evaluating unusual work schedules, exposure limits and body burdens of pollutants.
    Saltzman BE
    Am Ind Hyg Assoc J; 1988 May; 49(5):213-25. PubMed ID: 3400585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicokinetic and toxicodynamic considerations when deriving health-based exposure limits for pharmaceuticals.
    Reichard JF; Maier MA; Naumann BD; Pecquet AM; Pfister T; Sandhu R; Sargent EV; Streeter AJ; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S67-78. PubMed ID: 27224509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of intake above the ADI/TDI in relation to toxicodynamics and toxicokinetics.
    Renwick AG
    Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S69-78. PubMed ID: 10597617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adjustment of occupational exposure limits for unusual work schedules.
    Verma DK
    AIHAJ; 2000; 61(3):367-74. PubMed ID: 10885886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Timing of sample collection for biological monitoring of occupational exposure.
    Fiserova-Bergerova V; Vlach J
    Ann Occup Hyg; 1997 Jun; 41(3):345-53. PubMed ID: 9204759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Unusual work schedule: mathematical and pharmacokinetic models to adjust the occupational exposure limit of the chemical agents].
    Maina G; Cafaro R; Sorasio D; Rossi F
    G Ital Med Lav Ergon; 2011; 33(3 Suppl):28-30. PubMed ID: 23393793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limits to occupational exposure in chemical environments under novel work schedules.
    Mason JW; Dershin H
    J Occup Med; 1976 Sep; 18(9):603-6. PubMed ID: 966090
    [No Abstract]   [Full Text] [Related]  

  • 12. A systematic review of the sleep, sleepiness, and performance implications of limited wake shift work schedules.
    Short MA; Agostini A; Lushington K; Dorrian J
    Scand J Work Environ Health; 2015 Sep; 41(5):425-40. PubMed ID: 26103467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of occupational health risk during unusual workshifts: review of the needs and solutions for modifying environmental and biological limit values for volatile organic solvents.
    Goyal R; Krishnan K; Tardif R; Laparé S; Brodeur J
    Can J Public Health; 1992; 83(2):109-12. PubMed ID: 1617545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further comments on novel schedule TLVs.
    Calabrese EJ
    Am Ind Hyg Assoc J; 1977 Sep; 38(9):443-6. PubMed ID: 906958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the translation of uncertainty from toxicokinetic to toxicodynamic models--the TCDD example.
    Heinzl H; Mittlböck M; Edler L
    Chemosphere; 2007 Apr; 67(9):S365-74. PubMed ID: 17224175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological threshold limits for benzene based on pharmacokinetics of inhaled benzene in man.
    Berlin M; Holm S; Knutsson P; Tunek A
    Arch Toxicol Suppl; 1979; (2):305-10. PubMed ID: 288337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary: two seminal contributions of S. A. Roach to the evaluation and control of hazardous substances in air.
    Rappaport SM; Flynn M
    Ann Occup Hyg; 2003 Jul; 47(5):343-8. PubMed ID: 12855486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What work schedule characteristics constitute a problem to the individual? A representative study of Swedish shift workers.
    Åkerstedt T; Kecklund G
    Appl Ergon; 2017 Mar; 59(Pt A):320-325. PubMed ID: 27890143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary absorption and excretion of compounds in the gas phase: theoretical pharmacokinetic and toxicokinetic analysis.
    Veng-Pedersen P
    J Pharm Sci; 1984 Aug; 73(8):1136-41. PubMed ID: 6491919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of toxicokinetic models to establish biological exposure indicators.
    Fiserova-Bergerova V
    Ann Occup Hyg; 1990 Dec; 34(6):639-51. PubMed ID: 2291587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.